Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael Roehrle
Michael Roehrle
Medicine
Oral administration
Volume of distribution
Prodrug
Bioavailability
3
Papers
234
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection.
2016
Clinical and Experimental Gastroenterology
Christoph Sarrazin
Francesco Castelli
Pietro Andreone
Maria Buti
Massimo Colombo
Stanislas Pol
Filipe Calinas
Massimo Puoti
A. Olveira
Mitchell L. Shiffman
Jerry O. Stern
George Kukolj
Michael Roehrle
Stella Aslanyan
Qiqi Deng
Richard Vinisko
Federico Mensa
David R. Nelson
Show All
Source
Cite
Save
Citations (2)
Single-Ascending-Dose Pharmacokinetics and Safety of the Novel Broad-Spectrum Antifungal Triazole BAL4815 after Intravenous Infusions (50, 100, and 200 Milligrams) and Oral Administrations (100, 200, and 400 Milligrams) of Its Prodrug, BAL8557, in Healthy Volunteers
2006
Antimicrobial Agents and Chemotherapy
Anne Schmitt-Hoffmann
Brigitte Roos
Markus Heep
Michael Schleimer
Erhard Weidekamm
Tom Brown
Michael Roehrle
Christoph Beglinger
Show All
Source
Cite
Save
Citations (123)
Multiple-Dose Pharmacokinetics and Safety of the New Antifungal Triazole BAL4815 after Intravenous Infusion and Oral Administration of Its Prodrug, BAL8557, in Healthy Volunteers
2006
Antimicrobial Agents and Chemotherapy
Anne Schmitt-Hoffmann
Brigitte Roos
Jürgen Maares
Markus Heep
Jochen Spickerman
Erhard Weidekamm
Tom Brown
Michael Roehrle
Show All
Source
Cite
Save
Citations (109)
1